Literature DB >> 2689011

In vitro activity of terbinafine.

Y M Clayton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2689011     DOI： 10.1111/j.1365-2230.1989.tb00901.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN： 0307-6938            Impact factor:   3.470


× No keyword cloud information.
  7 in total

1.  Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents.

Authors:  F C Odds
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

Review 2.  Adverse drug reactions to systemic antifungals. Prevention and management.

Authors:  J R Perfect; M H Lindsay; R H Drew
Journal:  Drug Saf       Date:  1992 Sep-Oct       Impact factor: 5.606

3.  Terbinafine increases the plasma concentration of paroxetine after a single oral administration of paroxetine in healthy subjects.

Authors:  Norio Yasui-Furukori; Manabu Saito; Yoshimasa Inoue; Takenori Niioka; Yasushi Sato; Shoko Tsuchimine; Sunao Kaneko
Journal:  Eur J Clin Pharmacol       Date:  2006-11-24       Impact factor: 2.953

4.  Effects of temperature on anti-Candida activities of antifungal antibiotics.

Authors:  F C Odds
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

5.  Comparison of terbinafine and clotrimazole in treating tinea pedis.

Authors:  E G Evans; B Dodman; D M Williamson; G J Brown; R G Bowen
Journal:  BMJ       Date:  1993-09-11

6.  Candida albicans Infections: a novel porcine wound model to evaluate treatment efficacy.

Authors:  Joel Gil; Michael Solis; Alexander Higa; Stephen C Davis
Journal:  BMC Microbiol       Date:  2022-02-04       Impact factor: 3.605

Review 7.  Antifungal Treatment for Pityriasis Versicolor.

Authors:  Aditya K Gupta; Kelly A Foley
Journal:  J Fungi (Basel)       Date:  2015-03-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.